Driehaus Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Driehaus Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-314,059	Closed	-$10.4M	–	476
2020 Q2	$10.4M	Sell	314,059 -35,803	-10%	-$1.14M	0.25%	120
2020 Q1	$9.52M	Buy	349,862 +9,258	+3%	+$258K	0.32%	87
2019 Q4	$6.72M	Buy	+340,604	New	+$5.45M	0.18%	147
2015 Q3	–	Sell	-190,189	Closed	-$4.34M	–	653
2015 Q2	$4.34M	Sell	190,189 -26,443	-12%	-$527K	0.15%	166
2015 Q1	$3.29M	Buy	+216,632	New	+$2.81M	0.11%	228

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Driehaus Capital Management's MNTA Position: Q3 2020 in Review

Driehaus Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 314,059 shares — an estimated $10.4M sold.

Driehaus Capital Management first reported a position in MNTA in Q1 2015 and held it in 5 quarters. The position peaked at $10.4M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Driehaus Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Driehaus Capital Management sold 314,059 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10.4M.
Driehaus Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
Driehaus Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $10.4M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Driehaus Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.